Trial intelligence / Profile preview

Methodology Study of Electronic Diaries and Voice Acoustics in MDD

NCT00406952Phase 4Completed

Sponsor
Pfizer
Start
Nov 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Sertraline with Placebo (2 arms). Primary endpoint: Time to treatment response. Started Nov 2006; status: completed.

02

Drugs

sertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00406952.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00406952.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call